| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.6 / 5 (436) | Istanbul, Turkey | 25+ years | Lutetium-177 therapy, targeted drugs | Advanced or metastatic cancers | JCI-accredited oncology department with access to advanced targeted drugs and personalized therapy plans. Follows NCCN and ESMO protocols for precise treatment. | International Organization for Standardization, Joint Commission International | ||
| #2 | 4.6 / 5 (544) | Istanbul, Turkey | 33+ years | Lutetium-177 therapy, Actinium-225 therapy | Advanced prostate cancer with PSMA-targeted therapy | Offers specialized PSMA-targeted therapies with JCI accreditation and collaboration with Johns Hopkins Medicine. Doctors have 40+ publications in tumor biology and targeted therapy. | Planetree's Gold Certificate, International Accreditation System for Interventional Oncology Services (IASIOS) | ||
| #3 | 4.6 / 5 (165) | Istanbul, Turkey | 15+ years | Lutetium-177 therapy | Advanced cancer cases requiring precision treatment | Specializes in Lutetium-177 therapy with a dedicated targeted therapy team led by an experienced oncologist. Offers precise diagnostics with 3T MRI and innovative Elekta Versa HD radiotherapy system. | International Organization for Standardization, Joint Commission International | ||
| #4 | 4.6 / 5 (175) | Vienna, Austria | 44+ years | MRI of one area, Consultation with an oncologist | Patients wanting fast molecular results without repeat visits | Every case reviewed by an interdisciplinary tumour board. Liquid biopsy blood test detects early tumours. Oncologist among top 2% of scientists worldwide. ISO 9001 certified. | World's Best Hospitals 2021 by Newsweek, International Organization for Standardization | ||
| #5 | 4.5 / 5 (266) | Istanbul, Turkey | 20+ years | Lutetium-177 therapy | Metastatic colorectal cancer | JCI-accredited hospital with specialized oncology team. Offers Lutetium-177 therapy for targeted cancer treatment. Doctors recommend personalized treatment plans based on molecular test results. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) | ||
| #6 | 4.7 / 5 (3) | Xiamen, China | 40+ years | Premium Check up, Consultation with a neurosurgeon | — | — | — | ||
| #7 | 4.8 / 5 (9) | Istanbul, Turkey | 14+ years | Actinium-225 PSMA, lutetium-177 PSMA | — | Multidisciplinary tumor board designs targeted therapy plans based on genetic profiling. Real-time AI-supported MRI and PET/CT track progress. Turkey's first JCI-accredited hospital. | — | ||
| #8 | 4.5 / 5 | Chengdu, China | 35+ years100,000+ treatments | Chemotherapy combined with targeted therapy and immunotherapy, driver gene alteration testing | Patients needing biomarker-guided targeted therapy | — | — | ||
| #9 | 4.7 / 5 (496) | Barcelona, Spain | 23+ years23,000+ treatments | Lutetium-177 therapy, personalized targeted therapy based on genetic testing | Advanced melanoma with specific mutations | Offers personalized targeted therapy guided by genetic testing (NGS) for precise treatment. Clinic is JCI accredited with oncologists experienced in managing complex cases. | Joint Commission International , European Foundation for Quality Management | ||
| #10 | 5.0 / 5 (2) | Baku, Azerbaijan | — | — | Targeted therapy | — | — | — |